RxDoctor Payments Data

Margaret Cottle, NP

Nurse Practitioner · Goldsboro, NCNPI 1437206448

Payments from drug & device makers

$713in general payments, 2019–2025

Across 38 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$123
  • Novo Nordisk$122
  • Amgen$92
  • Exact Sciences$85
  • Otsuka America Pharmaceutical, Inc.$56
  • Lilly USA, LLC$51
  • plus $185 from 7 others

What the payments were for

  • Food & beverage$713100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$713 in reported general payments places this provider in the 70th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$41,482
Medicare patients
135
Services billed
851

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$56,685
JardianceEmpagliflozin36$42,345
JanuviaSitagliptin Phosphate37$40,910
Repatha SureclickEvolocumab55$33,554
EliquisApixaban32$31,627
RybelsusSemaglutide22$29,660
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$25,908
FarxigaDapagliflozin Propanediol13$12,175
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$3,983
SymbicortBudesonide/Formoterol Fumarate12$2,908
Gabapentin126$2,517
Rosuvastatin Calcium170$1,995
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$1,933
Albuterol Sulfate HfaAlbuterol Sulfate77$1,748
Atorvastatin Calcium136$1,337

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$122$86,34681 claims
Boehringer IngelheimJardiance$48$42,34536 claims
PfizerEliquis$15$31,62732 claims
GSKTrelegy Ellipta$28$25,90832 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Goldsboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →